New Approvals for TMS
The Carlat Psychiatry Report, Volume 16, Number 11 & 12, November 2018
https://www.thecarlatreport.com/newsletter-issue/tcprv16n11-12/
Issue Links: Learning Objectives | Editorial Information
Topics: Brain Devices | News of Note
Talia Puzantian, PharmD, BCPP
Chris Aiken, MD
Drs. Puzantian and Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We know that transcranial magnetic stimulation (TMS) works for treatment-resistant depression (TRD), but one disadvantage is the length of the treatment sessions.
You can't view details of this content, please login or buy subscription here